Atossa Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.60

+0.04 (+1.56%)

As of Aug 15, 2:24 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +223.8% upside

Low Target $5.85

Average Target $8.42

High Target $9.99

Current Price $2.60

Current
$2.60

Target
$8.42

$5.85 $8.42 avg $9.99

Scenario Analysis

Bear Case

$5.85

125.0%

Low target

Base Case

$8.42

+223.8%

Avg target

Bull Case

$9.99

+284.2%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$19.35

-86.6% from high

52-Week Low

$1.70

+52.9% from low

Target vs 52W High

$8.42

-56.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%